Cargando…
Inter-assay variability of next-generation sequencing-based gene panels
BACKGROUND: Tumor heterogeneity has been known to cause inter-assay discordance among next-generation sequencing (NGS) results. However, whether preclinical factors such as sample type, sample quality and analytical features of gene panel can affect the concordance between two different assays remai...
Autores principales: | Quy, Pham Nguyen, Fukuyama, Keita, Kanai, Masashi, Kou, Tadayuki, Kondo, Tomohiro, Yoshioka, Masahiro, Matsubara, Junichi, Sakuma, Tomohiro, Minamiguchi, Sachiko, Matsumoto, Shigemi, Muto, Manabu |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9013031/ https://www.ncbi.nlm.nih.gov/pubmed/35428255 http://dx.doi.org/10.1186/s12920-022-01230-y |
Ejemplares similares
-
BRCA2 Reversion Mutation Identified by Liquid Biopsy After Durable Response to FOLFIRINOX in BRCA2-Associated Pancreatic Cancer
por: Kondo, Tomohiro, et al.
Publicado: (2020) -
Comprehensive genomic profiling for patients with chemotherapy‐naïve advanced cancer
por: Kondo, Tomohiro, et al.
Publicado: (2020) -
Prevalence of pathogenic germline variants in the circulating tumor DNA testing
por: Yamamoto, Yoshihiro, et al.
Publicado: (2022) -
Cancer of unknown primary with EGFR mutation successfully treated with targeted therapy directed by clinical next-generation sequencing: a case report
por: Mitani, Yosuke, et al.
Publicado: (2020) -
Clinical sequencing using a next‐generation sequencing‐based multiplex gene assay in patients with advanced solid tumors
por: Kou, Tadayuki, et al.
Publicado: (2017)